Gold prices slip after rallying on Powell rate cut talk
In a recent development, Nina Capital Holdings Inc., a significant stakeholder in PetMed Express Inc. (NASDAQ:PETS), acquired 100,000 shares of the company’s common stock. The transaction, which took place on March 18, 2025, was executed at an average price of $4.085 per share, totaling approximately $408,500. According to InvestingPro data, this purchase comes as the stock trades at $4.08, with analysis suggesting the company is currently undervalued.
This purchase increases the total shares owned by Nina Capital Holdings to 2,500,000. The acquisition also includes shares held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman, who are both ten percent owners of PetMed Express. The company, with a market capitalization of $84 million, maintains a strong balance sheet with more cash than debt.
The transaction was reported in a Form 4 filing with the Securities and Exchange Commission, underscoring the continued interest of major stakeholders in the company. PetMed Express, based in Delray Beach, Florida, operates in the retail drug and proprietary stores sector. The company maintains healthy liquidity with a current ratio of 1.43, and InvestingPro analysis reveals 8 additional key insights about the company’s financial health and growth prospects.
In other recent news, PetMed Express reported its fourth-quarter 2024 earnings, revealing a net loss of $0.03 per share, which was larger than the forecasted loss of $0.01 per share. Revenue also fell short of expectations, coming in at $53 million compared to the anticipated $65 million, marking a 19% year-over-year decline. Despite the earnings miss, the company managed to improve its gross profit margin to 28.1%, an 80 basis points increase from the previous year, and adjusted EBITDA rose to $2 million from $900,000. Analysts from Lake Street Capital Markets have reiterated a Hold rating on the stock, citing ongoing competitive pressures and a lack of organic growth over the past 12 quarters. PetMed Express is actively working on transforming its business by reducing SKUs, enhancing its digital platforms, and targeting younger demographics and higher-income households. The company has also made significant strides in operational efficiency, reporting a reduction in general and administrative expenses by $2.6 million compared to the previous year. PetMed Express’s management remains focused on long-term shareholder value and is investing in customer experience improvements and marketing strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.